Cyclo Therapeutics, Inc.
CYTH · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,247 | $1,543 | $16,613 | $12,846 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $122 | $55 | $539 | $112 |
| Inventory | $254 | $254 | $227 | $238 |
| Other Curr. Assets | $2,695 | $2,306 | $2,057 | $854 |
| Total Curr. Assets | $12,318 | $4,159 | $19,436 | $14,050 |
| Property Plant & Equip (Net) | $929 | $57 | $77 | $88 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $7 | $50 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$57 | $0 | $0 |
| Total NC Assets | $929 | $57 | $84 | $138 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,248 | $4,215 | $19,521 | $14,188 |
| Liabilities | – | – | – | – |
| Payables | $4,857 | $2,234 | $3,678 | $3,541 |
| Short-Term Debt | $1,011 | $0 | $153 | $132 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$3,678 | -$3,541 |
| Other Curr. Liab. | $2,601 | $1,247 | $0 | $0 |
| Total Curr. Liab. | $8,468 | $3,481 | $3,831 | $3,673 |
| LT Debt | $22 | $0 | $18 | $63 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $22 | $3,481 | $18 | $63 |
| Other Liabilities | $0 | -$3,481 | $0 | $0 |
| Cap. Leases | $1,033 | $0 | $19 | $36 |
| Total Liabilities | $8,491 | $3,481 | $3,849 | $3,735 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $1 | $1 | $0 |
| Retained Earnings | -$83,857 | -$63,799 | -$48,348 | -$34,062 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $88,611 | $64,533 | $64,020 | $44,514 |
| Total Equity | $4,757 | $735 | $15,672 | $10,452 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,248 | $4,215 | $19,521 | $14,188 |
| Net Debt | -$8,213 | -$1,543 | -$16,442 | -$12,652 |